Incannex Healthcare Inc. current report, Q4 FY2022

Incannex Healthcare Limited — Form 6-K Summary

Reporting period: November 2022; filed November 21, 2022. Incannex Healthcare Limited is an Australian foreign private issuer filing under Form 20-F.

Business Context

The filing reports that the company submitted an Australian Securities Exchange announcement titled “Addendum to Notice of Annual General Meeting.” The announcement is incorporated as Exhibit 99.1, but its substantive contents are not included in the provided filing text.

Financial and Operating Metrics

The filing text does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, balance-sheet data, operating statistics, or other financial metrics.

Material Changes Versus Prior Period

No financial or operational comparison with a prior period is provided. The only reported development is the issuance of an addendum to the notice of the company’s annual general meeting.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not provide management guidance, outlook, risk disclosures, contingencies, or unusual financial items. The details of the annual general meeting addendum cannot be assessed because Exhibit 99.1 is referenced but not reproduced in the source text.

Facts Investors Should Verify

  • Review Exhibit 99.1 to determine the substantive changes made to the annual general meeting notice.
  • Verify whether the addendum affects meeting resolutions, voting procedures, timing, or shareholder action requirements.
  • Consult the company’s financial filings for current revenue, cash position, funding requirements, debt, and clinical or operating developments, none of which are addressed here.